{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "22247440",
  "DateCompleted": {
    "Year": "2012",
    "Month": "05",
    "Day": "03"
  },
  "DateRevised": {
    "Year": "2012",
    "Month": "01",
    "Day": "16"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1093/cid/cir862"
    ],
    "Journal": {
      "ISSN": "1537-6591",
      "JournalIssue": {
        "Volume": "54 Suppl 1",
        "PubDate": {
          "Year": "2012",
          "Month": "Feb"
        }
      },
      "Title": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",
      "ISOAbbreviation": "Clin Infect Dis"
    },
    "ArticleTitle": "Meeting the challenges of an emerging pathogen: the Henry Schueler 41&9 Foundation International Forum on Mucormycosis.",
    "Pagination": {
      "StartPage": "S1",
      "EndPage": "S4",
      "MedlinePgn": "S1-4"
    },
    "Abstract": {
      "AbstractText": [
        "Invasive mucormycosis comprises a group of uncommon but emerging life-threatening pulmonary, sinal, rhinocerebral, and disseminated infections, which cause debilitating morbidity and severe mortality in our most vulnerable pediatric and adult immunocompromised patients. While important advances are being achieved in understanding the epidemiology, molecular taxonomy, pathogenesis, pharmacology, host defenses, and microbiology of these infections, there are critical needs for improving these approaches for diagnosis, treatment, and prevention. This supplement is dedicated to the memory and courage of Hank Schueler, who fought valiantly against this infection. It provides a comprehensive resource for current approaches to management of this infection and also reviews the key advances against invasive mucormycosis."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Transplantation-Oncology Infectious Diseases Program, Weill Cornell University Medical Center, 1300 York Avenue, New York, NY 10065, USA. thw2003@medcornelledu"
          }
        ],
        "LastName": "Walsh",
        "ForeName": "Thomas J",
        "Initials": "TJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Bloom",
        "ForeName": "Bruce E",
        "Initials": "BE"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kontoyiannis",
        "ForeName": "Dimitrios P",
        "Initials": "DP"
      }
    ],
    "PublicationTypeList": [
      "Introductory Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Clin Infect Dis",
    "NlmUniqueID": "9203213",
    "ISSNLinking": "1058-4838"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [
        "diagnosis",
        "drug therapy",
        "epidemiology",
        "immunology",
        "microbiology"
      ],
      "DescriptorName": "Communicable Diseases, Emerging"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "International Cooperation"
    },
    {
      "QualifierName": [
        "immunology",
        "pathogenicity"
      ],
      "DescriptorName": "Mucorales"
    },
    {
      "QualifierName": [
        "diagnosis",
        "drug therapy",
        "epidemiology",
        "immunology",
        "microbiology"
      ],
      "DescriptorName": "Mucormycosis"
    }
  ]
}